The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
Abstract
Fibrolamellar carcinoma (FLC) is a rare liver cancer. FLCs uniquely produce DNAJ-PKAc, a chimeric enzyme consisting of a chaperonin-binding domain fused to the Cα subunit of protein kinase A. Biochemical analyses of clinical samples reveal that a unique property of this fusion enzyme is the ability to recruit heat shock protein 70 (Hsp70). This cellular chaperonin is frequently up-regulated in cancers. Gene-editing of mouse hepatocytes generated disease-relevant AML12DNAJ-PKAc cell lines. Further analyses indicate that the proto-oncogene A-kinase anchoring protein-Lbc is up-regulated in FLC and functions to cluster DNAJ-PKAc/Hsp70 sub-complexes with a RAF-MEK-ERK kinase module. Drug screening reveals Hsp70 and MEK inhibitor combinations that selectively block proliferation of AML12DNAJ-PKAc cells. Phosphoproteomic profiling demonstrates that DNAJ-PKAc biases the signaling landscape toward ERK activation and engages downstream kinase cascades. Thus, the oncogenic action of DNAJ-PKAc involves an acquired scaffolding function that permits recruitment of Hsp70 and mobilization of local ERK signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fourth, PKA-CDNAJB1 may form stable complexes with Hsp70, with the J-domain acting as a scaffold for this chaperonin16.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [16]
In the citing paper
“Furthermore, these researchers showed that the phosphoproteomics of PKA-CDNAJB1 is different from that of the wild-type, implying that the J-domain skews the phosphorylation profile of cells toward alternative pathways16.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [16]
In the citing paper
“Therefore, the attenuation in allosteric binding cooperativity is likely to be implicated in the altered interactome and phosphoproteome16.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
Caunt, C. J., Sale, M. J., Smith, P. D., & Cook, S. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4000 · Cited by 606
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L., & Weinberg, R. A. (2016) · Science · doi:10.1126/science.aad3680 · Cited by 332
Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome
Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232
Research works printed but not linked: 70
- Aggarwal, 2019, Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility, Journal of Biological Chemistry, 294, 3152, 10.1074/jbc.RA118.006741 · DOI
- Ang, 2013, Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium, Gastrointestinal Cancer Research : GCR, 6, 3
- Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal cushing's syndrome, New England Journal of Medicine, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
- Burgers, 2012, A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane, Journal of Biological Chemistry, 287, 43789, 10.1074/jbc.M112.395970 · DOI
- Calderwood, 2006, Heat shock proteins in cancer: chaperones of tumorigenesis, Trends in Biochemical Sciences, 31, 164, 10.1016/j.tibs.2006.01.006 · DOI · Paper page
- Cao, 2019, Structures of the PKA riα holoenzyme with the FLHCC driver J-PKAcα or Wild-Type PKAcα, Structure, 27, 816, 10.1016/j.str.2019.03.001 · DOI · Paper page
- Carr, 1992, Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain, Journal of Biological Chemistry, 5, 13376, 10.1016/S0021-9258(18)42221-1 · DOI · Paper page
- Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, PNAS, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
- Cho, 2000, Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking calpha and RIIbeta subunit overexpression, PNAS, 97, 835, 10.1073/pnas.97.2.835 · DOI
- Cho-Chung, 2005, Tumor reversion: protein kinase A isozyme switching, Annals of the New York Academy of Sciences, 1058, 76, 10.1196/annals.1359.014 · DOI
- Cornella, 2015, Unique genomic profile of fibrolamellar hepatocellular carcinoma, Gastroenterology, 148, 806, 10.1053/j.gastro.2014.12.028 · DOI
- Craig, 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
- Cvijic, 2000, Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 6, 2309
- Dalby, 1998, Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK, Journal of Biological Chemistry, 273, 1496, 10.1074/jbc.273.3.1496 · DOI · Paper page
- Dinh, 2017, Comprehensive analysis of the cancer genome atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma, Scientific Reports, 7, 10.1038/srep44653 · DOI
- Diviani, 2001, AKAP-Lbc anchors protein kinase A and nucleates galpha 12-selective Rho-mediated stress fiber formation, The Journal of Biological Chemistry, 276, 44247, 10.1074/jbc.M106629200 · DOI · Paper page
- Dumaz, 2005, Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie lecture delivered on 5 July 2003 at the special FEBS meeting in Brussels, FEBS Journal, 272, 3491, 10.1111/j.1742-4658.2005.04763.x · DOI · Paper page
- Engelholm, 2017, CRISPR/Cas9 engineering of adult mouse liver demonstrates That the Dnajb1 – Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma, Gastroenterology, 153, 1662, 10.1053/j.gastro.2017.09.008 · DOI
- Eugênio, 2017, Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma, Oncotarget, 8, 114698, 10.18632/oncotarget.22815 · DOI
- Feramisco, 1980, Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase, The Journal of Biological Chemistry, 255, 4240, 10.1016/S0021-9258(19)85658-2 · DOI · Paper page
- Ficarro, 2009, Magnetic bead processor for rapid evaluation and optimization of parameters for phosphopeptide enrichment, Analytical Chemistry, 81, 4566, 10.1021/ac9004452 · doi:10.1021/ac9004452
- Golkowski, 2016, Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in leydig cell function with phosphoproteomics, Cellular Signalling, 28, 764, 10.1016/j.cellsig.2015.11.014 · DOI
- Golkowski, 2017, Kinobead and Single-Shot LC-MS profiling identifies selective PKD inhibitors, Journal of Proteome Research, 16, 1216, 10.1021/acs.jproteome.6b00817 · DOI
- Goloudina, 2012, Inhibition of HSP70: a challenging anti-cancer strategy, Cancer Letters, 325, 117, 10.1016/j.canlet.2012.06.003 · DOI · Paper page
- Graham, 2018, Fibrolamellar carcinoma in the Carney complex: prkar1a loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Hennessy, 2005, Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions, Protein Science, 14, 1697, 10.1110/ps.051406805 · DOI · Paper page
- Hogrebe, 2018, Benchmarking common quantification strategies for large-scale phosphoproteomics, Nature Communications, 9, 10.1038/s41467-018-03309-6 · DOI · Paper page
- Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- Horn, 2014, KinomeXplorer: an integrated platform for kinome biology studies, Nature Methods, 11, 603, 10.1038/nmeth.2968 · DOI · Paper page
- Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, PNAS, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
- Kastenhuber, 2019, Road map for fibrolamellar carcinoma: progress and goals of a diversified approach, Journal of Hepatocellular Carcinoma, 6, 41, 10.2147/JHC.S194764 · DOI
- Kolch, 2015, The dynamic control of signal transduction networks in cancer cells, Nature Reviews Cancer, 15, 515, 10.1038/nrc3983 · DOI · Paper page
- Lacroix, 2015, Cushing's syndrome, The Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 · DOI · Paper page
- Lalazar, 2018, Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms, Seminars in Liver Disease, 38, 051, 10.1055/s-0037-1621710 · DOI · Paper page
- Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nature Reviews Molecular Cell Biology, 16, 232, 10.1038/nrm3966 · DOI · Paper page
- Liu, 2018, The significance of intertumor and intratumor heterogeneity in liver cancer, Experimental & Molecular Medicine, 50, 10.1038/emm.2017.165 · DOI · Paper page
- Macario, 2007, Chaperonopathies by defect, excess, or mistake, Annals of the New York Academy of Sciences, 1113, 178, 10.1196/annals.1391.009 · DOI
- Mayer, 2005, Hsp70 chaperones: cellular functions and molecular mechanism, Cellular and Molecular Life Sciences, 62, 670, 10.1007/s00018-004-4464-6 · DOI · Paper page
- McCartney, 1995, Cloning and characterization of A-kinase anchor protein 100 (AKAP100), Journal of Biological Chemistry, 270, 9327, 10.1074/jbc.270.16.9327 · DOI
- Means, 2011, An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria, PNAS, 108, E1227, 10.1073/pnas.1107182108 · DOI
- Oikawa, 2015, Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells, Nature Communications, 6, 10.1038/ncomms9070 · DOI
- Olsen, 2010, Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis, Science Signaling, 3, 10.1126/scisignal.2000475 · DOI · Paper page
- Pauli, 2017, Personalized in vitro and In Vivo Cancer Models to Guide Precision Medicine, Cancer Discovery, 7, 462, 10.1158/2159-8290.CD-16-1154 · DOI · Paper page
- Porter, 2001, Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme, American Journal of Physiology-Lung Cellular and Molecular Physiology, 280, L1282, 10.1152/ajplung.2001.280.6.L1282 · DOI
- Pribluda, 2015, Intratumoral heterogeneity: from diversity comes resistance, Clinical Cancer Research, 21, 2916, 10.1158/1078-0432.CCR-14-1213 · DOI
- Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nature Protocols, 8, 2281, 10.1038/nprot.2013.143 · DOI · Paper page
- Rhayem, 2015, Functional characterization of PRKAR1A mutations reveals a unique molecular mechanism causing acrodysostosis but multiple mechanisms causing Carney complex, Journal of Biological Chemistry, 290, 27816, 10.1074/jbc.M115.656553 · DOI
- Riggle, 2016, Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma, Pediatric Research, 80, 110, 10.1038/pr.2016.36 · DOI · Paper page
- Riggle, 2016, Fibrolamellar hepatocellular carcinoma: Mechanistic distinction from adult hepatocellular carcinoma, Pediatric Blood & Cancer, 63, 1163, 10.1002/pbc.25970 · DOI · Paper page
- Rossomando, 1992, Identification of Tyr-185 as the site of tyrosine autophosphorylation of recombinant mitogen-activated protein kinase p42mapk, PNAS, 89, 5779, 10.1073/pnas.89.13.5779 · DOI
- Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
- Scott, 1985, Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle, PNAS, 82, 5732, 10.1073/pnas.82.17.5732 · DOI · Paper page
- Scott, 2009, Cell signaling in space and time: where proteins come together and when they're apart, Science, 326, 1220, 10.1126/science.1175668 · DOI · Paper page
- Simon, 2015, Transcriptomic characterization of fibrolamellar hepatocellular carcinoma, PNAS, 112, E5916, 10.1073/pnas.1424894112 · DOI · Paper page
- Smith, 2010, AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade, Nature Cell Biology, 12, 1242, 10.1038/ncb2130 · DOI
- Smith, 2017, Local protein kinase A action proceeds through intact holoenzymes, Science, 356, 1288, 10.1126/science.aaj1669 · DOI · Paper page
- Smith, 2018, Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins, PNAS, 115, E11465, 10.1073/pnas.1816614115 · DOI
- Stewart, 1999, Kinase suppressor of ras forms a multiprotein signaling complex and modulates MEK localization, Molecular and Cellular Biology, 19, 5523, 10.1128/MCB.19.8.5523 · DOI · Paper page
- Stratakis, 2013, cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse, Molecular and Cellular Endocrinology, 371, 208, 10.1016/j.mce.2013.01.015 · DOI
- Takahashi, 2017, Phosphorylation of Rap1 by cAMP-dependent protein kinase (PKA) Creates a binding site for KSR to sustain ERK activation by cAMP, Journal of Biological Chemistry, 292, 1449, 10.1074/jbc.M116.768986 · DOI
- Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nature Reviews Molecular Cell Biology, 13, 646, 10.1038/nrm3432 · DOI · Paper page
- Toyoshima, 2012, Functional genomics identifies therapeutic targets for MYC-driven cancer, PNAS, 109, 9545, 10.1073/pnas.1121119109 · DOI · Paper page
- Turnham, 2016, Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology, Gene, 577, 101, 10.1016/j.gene.2015.11.052 · DOI · Paper page
- Tyanova, 2016, The perseus computational platform for comprehensive analysis of (prote)omics data, Nature Methods, 13, 731, 10.1038/nmeth.3901 · DOI · Paper page
- Villén, 2008, The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry, Nature Protocols, 3, 1630, 10.1038/nprot.2008.150 · DOI · Paper page
- Wen, 2014, VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines, Experimental Biology and Medicine, 239, 638, 10.1177/1535370214527899 · DOI
- Whiting, 2015, Protein kinase A opposes the Phosphorylation-dependent recruitment of glycogen synthase kinase 3β to A-kinase anchoring protein 220, Journal of Biological Chemistry, 290, 19445, 10.1074/jbc.M115.654822 · DOI
- Wu, 1994, Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha, PNAS, 91, 674, 10.1073/pnas.91.2.674 · DOI · Paper page
- Xu, 2015, Genomic analysis of fibrolamellar hepatocellular carcinoma, Human Molecular Genetics, 24, 50, 10.1093/hmg/ddu418 · DOI · Paper page
Cited by
Phase Separation of a PKA Regulatory Subunit Controls cAMP Compartmentation and Oncogenic Signaling
Zhang, J. Z., Lu, T.-W., Stolerman, L. M., Tenner, B., Yang, J. R., Zhang, J.-F., Falcke, M., Rangamani, P., Taylor, S. S., Mehta, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.043 · Cited by 314
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Gritti, I., Wan, J., Weeresekara, V., Vaz, J. M., Tarantino, G., Bryde, T. H., Vijay, V., Kammula, A. V., Kattel, P., Zhu, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0634 · Cited by 20
Metadata
- Authors
- Turnham, R. E., Smith, F. D., Kenerson, H. L., Omar, M. H., Golkowski, M., Garcia, I., Bauer, R., Lau, H.-T., Sullivan, K. M., Langeberg, L. K., Ong, S.-E., Riehle, K. J., Yeung, R. S., & Scott, J. D.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2019-05-07
- Volume
- 8
- ISSN
- 2050-084X
- Cited by
- 61
- References
- 5
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- National Institutes of Health (2T32CA080416)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK121415, R01DK119192)
- National Cancer Institute (R21CA177402, R21CA201867)
- NIH Office of the Director (S10 OD021502)
- St. Baldrick's Foundation (Research Award)
- Fibrolamellar Cancer Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma. https://app.cochat.ai/papers/10.7554/elife.44187
- The paper
- Turnham, R. E., Smith, F. D., Kenerson, H. L., Omar, M. H., Golkowski, M., Garcia, I., Bauer, R., Lau, H.-T., Sullivan, K. M., Langeberg, L. K., Ong, S.-E., Riehle, K. J., Yeung, R. S., & Scott, J. D. (2019). An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma. eLife. https://doi.org/10.7554/elife.44187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.